Feedback / Questions
nesvacumab (REGN910) - Regeneron
Nesvacumab: "Results suggest improvement in vision and retinal morphology"
(Regeneron Pharmaceuticals)
-
Aug 19, 2017 -
ASRS 2017
P1 data
•
Age-related Macular Degeneration • Ophthalmology
http://files.shareholder.com/downloads/REGN/4505220901x0x953801/3E4FAB79-C350-43AD-90A4-C88FA69393B5/Phase_1_Study_of_Combination_Therapy_With_Nesvacumab_and_Aflibercept_.pdf
Aug 19, 2017
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious